PDF (1617K)
摘要
目的 探讨梅毒酶联免疫吸附试验(ELISA)单试剂阳性献血者归队的可行性,同时评估不同 ELISA 试剂检测 S/CO 值对真、假阳性标本的区分能力并确定不同试剂最佳判定阈值,为完善献血者归队策略提供科学依据。方法 回顾性收集 2 部分献血者资料:1)归队列队:2018 年 1 月 1 日-2025 年 12 月 31 日于江苏省血液中心申请归队的 106 名既往因抗-TP ELISA 单试剂阳性被屏蔽的献血者(新创试剂单阳 58 例名、科华试剂单阳 48 名);2)常规筛查确证队列:2024 年4 月-2026 年6 月常规献血筛查中抗-TP ELISA 单试剂阳性并加做 TPPA 的39 名献血者(新创试剂单阳 17 名、科华试剂单阳 22 名)。以 TPPA 结果为金标准,将 2 队列合并(新创试剂单阳 75 名、科华试剂单阳 70 名)后按试剂分别构建受试者操作特征(ROC)曲线,以 2 000 次 Bootstrap 估计曲线下面积(AUC)的 95%置信区间(CI),以最大约登指数确定各试剂最佳 S/CO 判定阈值,并按队列来源进行敏感性分析;同时比较归队检测单、双试剂阳性标本的 TPPA 确证阳性率。结果 归队列队 106 名献血者中,73 名归队成功,33 名归队失败。归队成功者标本屏蔽检测 S/CO 均值为 1.930(中位数 1.570),低于失败者的 3.487(中位数 2.592)(P<0.001)。33 名归队失败者标本中 TPPA 阳性 16 份,其中归队检测呈双试剂阳性 7 份(6 份 TPPA 阳性)、单试剂阳性 25 份(9 份 TPPA 阳性)、ELISA 阴性 1 份(TPPA 阳性)。归队检测双试剂阳性标本 TPPA 阳性率为 85.7%(6/7),高于单试剂阳性标本的 36.0%(9/25)(P=0.033);归队检测 2 种试剂阳性结果的一致性较差(Kappa=0.231)。合并标本 ROC 分析显示:新创试剂(n=75,TPPA 阳性 14 份)AUC 为 0.837(95%CI 0.731-0.929),最佳阈值为 2.025,对应敏感度 92.9%(13/14)、特异度 65.6%(40/61)、阴性预测值 97.6%(40/41);科华试剂(n=70,TPPA 阳性 13 份)AUC 为 0.787(95%CI 0.649-0.900),最佳阈值为 1.733,对应敏感度 92.3%(12/13)、特异度 56.1%(32/57)、阴性预测值 97.0%(32/33)。分队列敏感性分析显示,归队列队与筛查队列分别计算的 AUC 与合并分析方向一致。结论 新创与科华 2 种试剂 S/CO 值对 TPPA 确证的真、假阳性均具有区分能力,但最佳判定阈值不同。归队检测呈双试剂阳性高度提示 TPPA 确证阳性;单试剂阳性标本的 TPPA 阳性率随 S/CO 值升高呈梯度上升,低 S/CO 值单试剂阳性者多为假阳性。在归队机制中按试剂引入基于 S/CO 定量阈值的分层管理,有助于低风险假阳性献血者群体建立快速归队通道。
Abstract
Objective To evaluate the feasibility of re-entry for blood donors deferred for single-reagent reactive anti-TP ELISA results, to assess the ability of ELISA S/CO values of different kits to discriminate true-from false-positive samples and to determine the optimal cutoff value for each kit, thereby providing a scientific basis for improving blood donor re-entry strategies. Methods Data of two donor cohorts were retrospectively collected:(1) a re-entry cohort of 106 donors who applied for re-entry at Jiangsu Province Blood Center from January 1, 2018 to December 31, 2025, all previously deferred for single-reagent reactive anti-TP ELISA results (58 reactive with the Xinchuang kit and 48 with the Kehua kit); (2) a routine screening confirmation cohort of 39 donors found to be single-reagent reactive in routine donation screening and additionally tested by TPPA between April 2024 and June 2026 (17 Xinchuang and 22 Kehua). Using TPPA results as the gold standard, the two cohorts were pooled (75 Xinchuang, 70 Kehua), and receiver operating characteristic (ROC) curves were constructed separately for each kit. The 95% confidence interval (CI) of the area under the curve (AUC) was estimated with 2 000 bootstrap replicates, and the optimal S/CO cutoff of each kit was determined by the maximum Youden index; sensitivity analysis was performed by cohort source. In addition, TPPA-confirmed positivity rates were compared between single-and dual-reagent reactive samples at re-entry testing. Results Of the 106 donors in the re-entry cohort, 73 were successfully requalified and 33 failed. The mean S/CO value at deferral testing in successfully requalified donors was 1.930 (median 1.570), significantly lower than 3.487 (median 2.592) in failed donors (P<0.001). Among the 33 donors who failed requalification, 16 samples were TPPA positive; at re-entry testing, 7 were dual-reagent reactive (6 TPPA positive), 25 remained single-reagent reactive (9 TPPA positive), and 1 was ELISA non-reactive (TPPA positive). The TPPA positivity rate of dual-reagent reactive samples at re-entry testing was 85.7% (6/7), significantly higher than 36.0% (9/25) of single-reagent reactive samples (P = 0.033); the agreement between the two kits at re-entry testing was poor (Kappa= 0.231). ROC analysis of pooled samples showed that for the Xinchuang kit (n = 75, 14 TPPA positive), the AUC was 0.837 (95%CI:0.731-0.929) with an optimal cutoff of 2.025, corresponding to a sensitivity of 92.9% (13/14), a specificity of 65.6% (40/61) and a negative predictive value of 97.6% (40/41); for the Kehua kit (n = 70, 13 TPPA positive), the AUC was 0.787 (95%CI:0.649-0.900) with an optimal cutoff of 1.733, corresponding to a sensitivity of 92.3% (12/13), a specificity of 56.1% (32/57) and a negative predictive value of 97.0% (32/33). Sensitivity analysis by cohort showed that the AUCs calculated separately for the re-entry and screening cohorts were consistent in direction with the pooled analysis. Conclusion S/CO values of both the Xinchuang and Kehua ELISA kits can discriminate TPPA-confirmed true from false positives, but their optimal cutoffs differ. Dual-reagent reactivity at re-entry testing strongly indicates TPPA-confirmed positivity; the TPPA positivity rate of single-reagent reactive samples increases in a gradient with rising S/CO values, and single-reagent reactive samples with low S/CO values are mostly false positives. Incorporating kit-specific stratified management based on quantitative S/CO thresholds into the re-entry mechanism may help establish a fast-track re-entry pathway for low-risk false-positive donors.
关键词
Key words
[Author(id=1329502405968511039, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=li963353859@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502406035619905, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502405968511039, language=EN, stringName=Zhanghui LI, firstName=Zhanghui, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangsu Province Blood Center, Nanjing 210042, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502406085951554, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502405968511039, language=CN, stringName=李张晖, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏省血液中心,江苏 南京 210042, bio={"content":"李张晖(1998-),男,检验师,Email:li963353859@163.com
"}, bioImg=null, bioContent=李张晖(1998-),男,检验师,Email:li963353859@163.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502405888819259, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, xref=null, ext=[AuthorCompanyExt(id=1329502405905596476, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangsu Province Blood Center, Nanjing 210042, China), AuthorCompanyExt(id=1329502405918179389, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏省血液中心,江苏 南京 210042)])]), Author(id=1329502406136283205, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502406199197767, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406136283205, language=EN, stringName=Wenjia HU, firstName=Wenjia, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangsu Province Blood Center, Nanjing 210042, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502406245335112, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406136283205, language=CN, stringName=胡文佳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏省血液中心,江苏 南京 210042, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502405888819259, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, xref=null, ext=[AuthorCompanyExt(id=1329502405905596476, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangsu Province Blood Center, Nanjing 210042, China), AuthorCompanyExt(id=1329502405918179389, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏省血液中心,江苏 南京 210042)])]), Author(id=1329502406295666763, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502406358581327, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406295666763, language=EN, stringName=Tao FENG, firstName=Tao, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangsu Province Blood Center, Nanjing 210042, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502406404718674, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406295666763, language=CN, stringName=冯涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏省血液中心,江苏 南京 210042, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502405888819259, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, xref=null, ext=[AuthorCompanyExt(id=1329502405905596476, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangsu Province Blood Center, Nanjing 210042, China), AuthorCompanyExt(id=1329502405918179389, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏省血液中心,江苏 南京 210042)])]), Author(id=1329502406459244629, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502406526353498, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406459244629, language=EN, stringName=Chen WU, firstName=Chen, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangsu Province Blood Center, Nanjing 210042, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502406576685149, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406459244629, language=CN, stringName=吴晨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏省血液中心,江苏 南京 210042, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502405888819259, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, xref=null, ext=[AuthorCompanyExt(id=1329502405905596476, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangsu Province Blood Center, Nanjing 210042, China), AuthorCompanyExt(id=1329502405918179389, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏省血液中心,江苏 南京 210042)])]), Author(id=1329502406627016800, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jiangnizhen@hotmail.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329502406698319973, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406627016800, language=EN, stringName=Nizhen JIANG, firstName=Nizhen, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangsu Province Blood Center, Nanjing 210042, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502406748651623, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, authorId=1329502406627016800, language=CN, stringName=蒋昵真, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江苏省血液中心,江苏 南京 210042, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502405888819259, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, xref=null, ext=[AuthorCompanyExt(id=1329502405905596476, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangsu Province Blood Center, Nanjing 210042, China), AuthorCompanyExt(id=1329502405918179389, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449374875484214, companyId=1329502405888819259, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江苏省血液中心,江苏 南京 210042)])])]
李张晖,胡文佳,冯涛,吴晨,蒋昵真.
基于ELISAS/CO值与TPPA确证结果的梅毒单试剂阳性献血者归队机制研究[J].
中国输血杂志, 2026, 39(8): 1117-1124 DOI:10.13303/j.cjbt.issn.1004-549x.2026.08.018
| [1] |
GHANEM K G, RAM S, RICE P A. The modern epidemic of syphilis[J].N Engl J Med, 2020, 382(9): 845-854.
|
| [2] |
杨立新,曾劲峰,许晓绚,等. 血液筛查中梅毒实验方法适用性探讨[J].国际检验医学杂志,2006,27(2): 108-110.
|
| [3] |
YANG L X, ZENG J F, XU X X, et al. Study on the feasibility of syphilis examination in blood screening[J].Int J Lab Med, 2006, 27(2):108-110.
|
| [4] |
邹姣丽,陈庆恺,袁秋婷,等. 无偿献血者梅毒螺旋体抗体反应性确证结果研究[J].中国输血杂志,2024, 37(7):790-796.
|
| [5] |
ZOU J L, CHEN Q K, YUAN Q T, et al. Study on the confirmation of treponema pallidum antibody reactivity in blood donors[J].Chin J Blood Transfusion, 2024, 37 (7):790-796.
|
| [6] |
PEELING R W, MABEY D, KAMB M L, et al. Syphilis[J].Nat Rev Dis Primers, 2017, 3:17073.
|
| [7] |
蒋昵真,王金花,濮云峰,等. 江苏省血液检测阳性献血者保留和归队经验探讨[J].中国输血杂志,2019, 32(11):1155-1159.
|
| [8] |
JIANG N Z, WANG J H, PU Y F, et al. Experiences on the retention and reentry of reactive blood donors in Jiangsu Province[J].Chin J Blood Transfusion, 2019, 32(11):1155-1159.
|
| [9] |
KORENROMP E L, ROWLEY J, ALONSO M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-estimates for 2016 and progress since 2012[J].PLoS ONE, 2019, 14 (2): e0211720.
|
| [10] |
SILVERSTEIN M, WONG J B, DAVIS E M, et al. Screening for syphilis infection during pregnancy: US Preventive Services Task Force reaffirmation recommendation statement[J].JAMA, 2025, 333 (22):2006-2012.
|
| [11] |
LI J, YANG Y, HUANG B, et al. Epidemiological characteristics of syphilis in mainland China, 2004 to 2019[J].J Int Med Res, 2024, 52(6):3000605241258465.
|
| [12] |
WORKOWSKI K A, BACHMANN L H, CHAN P A, et al. Sexually transmitted infections treatment guidelines, 2021[J].MMWR Recomm Rep, 2021, 70(4):1-187.
|
| [13] |
SPITERI G, UNEMO M, MÅRDH O, et al. The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe[J].Epidemiol Infect, 2019, 147: e143.
|
| [14] |
WHO. Guidelines for the treatment of treponema pallidum (syphilis)[M]. Geneva:World Health Organization,2016.
|
| [15] |
王伟,袁君,李娜,等. 输血前患者传染病检测为弱阳性结果的准确性探讨[J].东南国防医药,2021,23 (5):471-474.
|
| [16] |
WANG W, YUAN J, LI N, et al. Discussion on the accuracy of weak positive results of infectious disease detection in patients before blood transfusion[J].Mil Med J Southeast China, 2021, 23(5):471-474.
|
| [17] |
魏旖辉,王艺芳,陈明军,等. 无偿献血者梅毒 ELISA 不合格结果与 TPPA 确证试验的对比分析[J].临床血液学杂志,2025,38(2):122-125,130.
|
| [18] |
WEI Y H, WANG Y F, CHEN M J, et al. Comparative analysis of unqualified results of syphilis ELISA test and TPPA confirmation test among voluntary blood donors[J].J Clin Hematol, 2025, 38(2):122-125, 130.
|
| [19] |
HOOK E W 3rd, MARRA C M. Acquired syphilis in adults[J].N Engl J Med, 1992, 326(16):1060-1069.
|
| [20] |
TUCKER J D, CHEN X S, PEELING R W. Syphilis and social upheaval in China[J].N Engl J Med, 2010, 362(18):1658-1661.
|